Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Dis Aquat Organ ; 147: 47-61, 2021 Nov 18.
Artigo em Inglês | MEDLINE | ID: mdl-34789587

RESUMO

Sponges are fundamental components of coral reef communities and, unfortunately, like other major benthic members, they too have been impacted by epizootic and panzootic events. We report on the prevalence of disease-like conditions affecting populations of the giant barrel sponge Xestospongia muta across shallow and mesophotic coral reefs off La Parguera Natural Reserve (LPNR) and Mona Island Marine Reserve (MIMR) in Puerto Rico. Four different conditions affecting X. muta were observed during our surveys, of which 3 have been previously reported: cyclic spotted bleaching (CSB; apparently non-lethal), Xestospongia-tissue wasting disease (X-TWD; apparently lethal), and sponge orange band disease (SOB; sparsely associated with X-TWD infected individuals). Additionally, we describe a fourth condition, Xestospongia-tissue hardening condition (X-THC), a previously unreported disease recently observed along the insular shelf margin off LPNR and MIMR. Within LPNR, a total of 764 specimens of X. muta were inspected and measured. Of these, 590 sponges (72.2%) had CSB, 25 (3.27%) had signs of X-TWD, 7 (0.92%) had SOB, and the remaining 142 (18.6%) were apparently healthy. Three colonies inhabiting upper mesophotic depths on the LPNR insular shelf showed signs of CSB and X-TWD. At MIMR, video-transect surveys revealed a total of 514 colonies, of which 40 (7.78%) had signs of CSB and/or XTWD, 14 (2.72%) were affected by X-THC, while the remaining 460 (89.5%) showed no external signs of disease and appeared healthy. The presence of 4 concomitant disease-like conditions in barrel sponges of Puerto Rico is alarming, and indicative of the deteriorating status of Caribbean coral reefs.


Assuntos
Antozoários , Xestospongia , Animais , Recifes de Corais , Ecossistema , Porto Rico/epidemiologia
2.
Eur J Neurosci ; 27(2): 294-300, 2008 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-18190522

RESUMO

Administration of VP025 (Vasogen Inc.), a novel drug formulation based on phospholipid nanoparticles incorporating phosphatidylglycerol, has previously been shown to have a neuroprotective effect in the brain. We examined the effect of VP025 in a rat model of Parkinson's disease, the 6-hydroxydopamine (6-OHDA) lesion of the medial forebrain bundle. VP025 or phosphate-buffered saline (PBS) was administered to rats 14 days, 13 days and 1 day before the unilateral 6-OHDA lesion. Functional integrity of nigrostriatal dopaminergic neurons was assessed 7 and 21 days later by amphetamine-induced rotational testing and we observed that rotational counts were significantly less in rats that were pretreated with VP025 compared with PBS-pretreated 6-OHDA-lesioned rats. Neurochemical analysis at 10 and 28 days after lesion revealed that VP025 protected against a 6-OHDA-induced decrease in concentrations of striatal dopamine and its metabolites. Immunocytochemical studies of the ipsilateral substantia nigra showed that VP025 significantly inhibited 6-OHDA-induced loss of dopaminergic neurons. We also observed that increases in immunostaining for activated microglia and for activated p38 in dopaminergic neurons of 6-OHDA-lesioned rats were prevented by VP025. This study shows that VP025 has significant protective effects on the 6-OHDA-lesioned nigrostriatal pathway and may therefore have potential for the treatment of Parkinson's disease.


Assuntos
Modelos Animais de Doenças , Fármacos Neuroprotetores/uso terapêutico , Oxidopamina/toxicidade , Doença de Parkinson Secundária/tratamento farmacológico , Fosfatidilgliceróis/uso terapêutico , Fosfolipídeos/uso terapêutico , Animais , Masculino , Fármacos Neuroprotetores/química , Doença de Parkinson Secundária/induzido quimicamente , Doença de Parkinson Secundária/metabolismo , Doença de Parkinson Secundária/patologia , Fosfatidilgliceróis/química , Fosfolipídeos/química , Ratos , Ratos Sprague-Dawley
4.
Med J Aust ; 1(7): 311-3, 1982 Apr 03.
Artigo em Inglês | MEDLINE | ID: mdl-6806586

RESUMO

Seventeen insulin-dependent diabetics reused 111 disposable plastic syringes (Terumo 40/80-U; detachable needle) a total of 2363 times. Each syringe was used for an average of 12.2 days (range, one to 80 days), making an average of 21.3 injections each (range, two to 126 injections). There were no injection-related infections or local reactions. Six syringes from four patients were contaminated by non-pathogenic skin organisms (Staphylococcus albus and Bacillus spp.) without any detrimental effects. Contamination was independent of duration of syringe use or skin preparation technique. The reuse of plastic disposable insulin syringes appears to be a safe, cost-saving practice.


Assuntos
Equipamentos Descartáveis/economia , Insulina/administração & dosagem , Seringas , Adolescente , Adulto , Idoso , Criança , Análise Custo-Benefício , Diabetes Mellitus/tratamento farmacológico , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Nariz/microbiologia , Estações do Ano , Pele/microbiologia , Staphylococcus/isolamento & purificação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA